Recommendations From The 2023 International Evidence-Based Guideline For The Assessment And Management Of Polycystic Ovary Syndrome

    August 2023 in “ European journal of endocrinology ”
    Helena Teede, Chau Thien Tay, Joop S.E. Laven, Anuja Dokras, Lisa J. Moran, Terhi Piltonen, Michael Costello, Jacky Boivin, Leanne M. Redman, Jacqueline Boyle, Robert J. Norman, Aya Mousa, Anju E. Joham
    Image of study
    TLDR The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.
    The 2023 international guideline for the assessment and management of polycystic ovary syndrome (PCOS) recommends a comprehensive approach to diagnosis and treatment, including lifestyle changes, medication, and psychological support. The guideline, formulated by an international panel of experts, emphasizes early detection and management of associated risks such as diabetes, cardiovascular disease, and mental health issues. It provides 254 recommendations for managing PCOS, including patient empowerment, recognition of broader PCOS features, and evidence-based medical therapy. The guideline also suggests using total and free testosterone for diagnosing biochemical hyperandrogenism in PCOS, with hirsutism being a strong predictor of PCOS in adults. It recommends an OGTT test at 24-28 weeks gestation for all women with PCOS, regardless of BMI, due to increased risks of sleep apnea, endometrial hyperplasia, and cancer. The guideline suggests treatments such as lifestyle changes, medication, and laser hair removal to manage symptoms. It also identifies PCOS as a common condition that increases the risk of several health issues including cardiovascular disease, type 2 diabetes, and psychological disorders.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 12 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 2 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community C’est terrible - at my wits end

      in Female  443 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  56 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 5 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

    Similar Research

    6 / 1000+ results